Movement Disorder

Showing 1–12 of 80 results

EREPORT

How to Assess Tardive Dyskinesia Symptom Improvement With Measurement-Based Care

Measurement-based care (MBC) has been found to be effective in patients with psychiatric conditions. In this CME activity, learn how Dr Joseph McEvoy employs MBC for patients with tardive dyskinesia.

Joseph P. McEvoy

EREPORT

Collaborating With Patients to Make Treatment Decisions Based on Benefits and Risks of Medications Associated With Tardive Dyskinesia

Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.

Andrew A. Nierenberg

REVIEW ARTICLE

Psychiatric Disorder in Postural Orthostatic Tachycardia Syndrome and Ehlers-Danlos Syndrome-Hypermobility Type

Postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome-hypermobility type are associated with neuropsychiatric complications. Read this informative review article to find out more.

Ahmed Saeed Yahya and Shakil Khawaja

META-ANALYSIS

Pharmacologic Treatment of Tardive Dyskinesia: A Meta-Analysis and Systematic Review

Many augmentation agents have been examined regarding efficacy for antipsychotic-induced tardive dyskinesia (TD).The goal of this systematic review and meta-analysis was to examine the efficacy of these agents used in the treatment of TD.

Bekir B. Artukoglu & more

EDUCATIONAL ACTIVITY

Earlier Diagnosis of Tardive Dyskinesia

Do you proactively assess patients for tardive dyskinesia? Here, learn about screening and diagnosis from an expert.

Daniel E. Kremens

CASE REPORT

Antioxidants for the Treatment of Tardive Dyskinesia: AIMing to Find the Best Treatment Option

This case report illustrates the importance of the utilization of antioxidants for treatment of tardive dyskinesia. Read on to find out more.

O. Greg Deardorff & more

ACADEMIC HIGHLIGHTS

Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning

Some antipsychotics used to treat MDD are associated with activating or sedating effects. In this Academic Highlights, 4 experts offer clinical insights into the impact of these effects on treatment adherence, patient functioning, and quality of life.

Leslie L. Citrome & more

LETTERS TO THE EDITOR

Risperidone-Induced Tardive Dyskinesia in an Autistic Child

The majority of reported cases of risperidone-induced tardive dyskinesia occurred within 1 year after starting the neuroleptic. However, sometimes there was no cause-and-effect relationship of risperidone and tardive dyskinesia. The objective in presenting this particular case is to highlight the challenges in detecting risperidone-induced tardive dyskinesia in the medical setting.

Vasco Kidd

BRIEF REPORT

Exposure and Response Prevention for Comorbid Symptoms of Obsessive-Compulsive Disorder and Psychogenic Movement Disorder

Psychogenic movement disorders (PMDs) are common and frequently comorbid with other physical and psychiatric conditions. However, treatment of PMDs has been largely unsuccessful. This report describes a patient initially diagnosed with a PMD, who later received a diagnosis of comorbid OCD.Â Treatment with exposure and response prevention, an evidence-based psychotherapy for OCD, was successful in treating both conditions. Read on to find out more.

Daniel F. Gros & more

EDUCATIONAL ACTIVITIES

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options

Do you know which of your patients are at risk for developing tardive dyskinesia? Watch this Webcast to learn about how to prevent tardive dyskinesia in your patients and new treatment strategies for your patients who have already been diagnosed.

J. Sloan Manning and Joseph P. McEvoy

EDUCATIONAL ACTIVITIES

Discussing the Risk of Tardive Dyskinesia With Patients and Screening for Signs

Your patients taking antipsychotics may be at risk for developing tardive dyskinesia. In this Case and Comment activity, follow Martha, a 60-year-old woman being treated with an antipsychotic medication for her treatment-resistant depression.

J. Sloan Manning

EDUCATIONAL ACTIVITIES

Evidence-Based Strategies for Managing Tardive Dyskinesia

Do you know how to manage tardive dyskinesia symptoms? In this Case and Comment activity, consider the case of John, a 25-year-old project manager diagnosed with bipolar disorder who has begun exhibiting symptoms of uncontrollable movement.

Joseph P. McEvoy

…

Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects

In addition to altering one’s perception of reality, psychedelics may be useful for trea...

Avinash Hosanagar & more

JCP JOURNAL-BASED CME - ORIGINAL RESEARCH

Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study

How does comorbid attention-deficit/hyperactivity disorder (ADHD) affect individuals with ...

Kristopher A. Kast & more

ASCP CORNER

Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2: Review of the Evidence

Could psychedelics such as psilocybin and LSD be useful in treating MDD or other psychiatr...

Avinash Hosanagar & more

Movement Disorder

Sign-up to stay up-to-date today!

Already registered? Sign In

Sign-up to stay
up-to-date today!